Hims & Hers (HIMS 6. 76%) is attracting investors looking to buy the dip in this impressive growth stock. *Stock prices used were the afternoon prices of June 24, 2025.
The was published on June 26, 2025. Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health.
The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for moting its services.
If you choose to through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.